Czechia· CZ-0286095
KORJUNY
A catumaxomab product containing catumaxomab, registered in Czechia by Atnahs Pharma Netherlands B.V., Amsterdam. The same ATC class is registered in 9 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Catumaxomab is registered in 9 of 19 countries.
Countries holding a registration under ATC L01FX03 (catumaxomab), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Catumaxomab · ATC L01FX03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
SÚKL (Czech Republic)- Active substance
- CATUMAXOMAB
- Manufacturer
- Atnahs Pharma Netherlands B.V., Amsterdam
- Country
- Czechia (CZ)
- ATC code
- L01FX03
- ATC class
- Catumaxomab
- Defined daily dose
- 21 mcg, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Catumaxomab in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumKorjuny 10 µgAtnahs Pharma Netherlands
- FinlandRemovabNeovii Biotech GmbH
- PolandKORJUNYLindis Biotech GmbH
- SwedenKorjuny 10 mikrogram Koncentrat till infusionsvätska, lösningAtnahs Pharma Netherlands B.V.
- SpainKORJUNY 10 MICROGRAMOS CONCENTRADO PARA SOLUCION PARA PERFUSIONAtnahs Pharma Netherlands Bv.
- IcelandKorjunyAtnahs Pharma Netherlands B.V.
- NetherlandsKorjuny 10 microgram concentraat voor oplossing voor infusieAtnahs Pharma Netherlands B.V.
- United KingdomRemovab 10micrograms/0.1ml concentrate for solution for infusion pre-filled syringesNeovii Biotech GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Korjuny
- Liechtenstein · Korjuny
- Norway · Korjuny
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/25208672-e74f-408f-b3be-06f95b689d6c GET /v1/drugs/25208672-e74f-408f-b3be-06f95b689d6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INF CNC SOL",
"source": "sukl",
"strength": "10MCG",
"pack_size": "3X0,1ML+5KAN",
"substance": "CATUMAXOMAB",
"cz_kod_sukl": "0286095",
"product_type": "BT",
"substance_codes": "17389",
"registration_state": "R",
"registration_number": "EU/1/24/1826/001"
}See everything about catumaxomab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.